How does CRISPR activation (CRISPRa) work for gene upregulation?

CRISPRa uses catalytically dead Cas9 (dCas9) fused to transcriptional activators to upregulate gene expression without editing DNA. Early systems used VP64 (four copies of VP16). Synergistic activation mediator (SAM) combines dCas9-VP64 with modified gRNA containing MS2 aptamers that recruit MS2-p65-HSF1 activators. VPR system fuses VP64-p65-Rta for stronger activation. SunTag uses repeating epitope tags on dCas9 to recruit multiple activation domains via antibody fusions. Guides target promoter regions upstream of TSS. CRISPRa enables gain-of-function studies, activation screens, therapeutic upregulation of protective genes, and cellular reprogramming. Combined with CRISPRi, it enables bidirectional control.